160 Ten-year clinical outcomes post treatment with mitoxantrone for relapsing remitting MS

Mitoxantrone has been used as induction or escalation treatment in highly-active relapsing-remitting multiple sclerosis (RRMS). Whilst effective, its use is limited by adverse events (AE). Objective To report the clinical effectiveness and AE profile following mitoxantrone in a patient cohort with RRMS over a 10-year follow-up period. Methods This retrospective study included all patients treated with mitoxantrone in the Leeds MS service between...